<DOC>
	<DOC>NCT02041624</DOC>
	<brief_summary>The purpose of the present study is to describe patient's perception of quality of life and effectiveness of ORALAIR速 over a follow-up period up to 5 years, in real-life settings.</brief_summary>
	<brief_title>International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis</brief_title>
	<detailed_description>Primary objective: To describe the patient's perception of the impact of ORALAIR速 on his/her health related generic and disease specific quality of life during the grass pollen season in real-life settings. Secondary objectives: - To describe the patient's perceived effectiveness of ORALAIR速 in allergic rhinoconjunctivitis management in terms of disease intensity, satisfaction and rescue medication</detailed_description>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Patient of 5 years of age and older at the date of the screening visit Patient with proven allergic rhinoconjunctivitis due to grass pollen Patient eligible for a grasspollen Allergen ImmunoTherapy (AIT) Patient whose physician prescribed ORALAIR速 independently of the study, before the beginning of the grasspollen season Patient participating in a clinical trial or in an epidemiological study</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>allergic</keyword>
	<keyword>rhinitis</keyword>
	<keyword>conjunctivitis</keyword>
	<keyword>grass pollen</keyword>
	<keyword>Allergen ImmunoTherapy (AIT)</keyword>
	<keyword>grass mix</keyword>
</DOC>